Person:
Dumontel, Bianca

Profile Picture
First Name
Bianca
Last Name
Dumontel
URI
https://hdl.handle.net/20.500.14352/85695
Affiliation
Universidad Complutense de Madrid
Faculty / Institute
Farmacia
Department
Química en Ciencias Farmacéuticas
Area
Identifiers
UCM identifierORCIDScopus Author IDDialnet ID

Filters

2019 - 201912020 - 20232
Reset filters

Settings

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Bioinspired extracellular vesicle-coated silica nanoparticles as selective delivery systems
    (Materials Today Bio, 2023) Dumontel, Bianca; Jiménez-Jiménez, Carla; Vallet Regí, María Dulce Nombre; Manzano García, Miguel
    In recent years, there has been a breakthrough in the integration of artificial nanoplatforms with natural biomaterials for the development of more efficient drug delivery systems. The formulation of bioinspired nanosystems, combining the benefits of synthetic nanoparticles with the natural features of biological materials, provides an efficient strategy to improve nanoparticle circulation time, biocompatibility and specificity toward targeted tissues. Among others biological materials, extracellular vesicles (EVs), membranous structures secreted by many types of cells composed by a protein rich lipid bilayer, have shown a great potential as drug delivery systems themselves and in combination with artificial nanoparticles. The reason for such interest relays on their natural properties, such as overcoming several biological barriers or migration towards specific tissues. Here, we propose the use of mesoporous silica nanoparticles (MSNs) as efficient and versatile nanocarriers in combination with tumor derived extracellular vesicles (EVs) for the development of selective drug delivery systems. The hybrid nanosystems demonstrated selective cellular internalization in parent cells, indicating that the EV targeting capabilities were efficiently transferred to MSNs by the developed coating strategy. As a result, EVs-coated MSNs provided an enhanced and selective intracellular accumulation of doxorubicin and a specific cytotoxic activity against targeted cancer cells, revealing these hybrid nanosystems as promising candidates for the development of targeted treatments.
  • Thumbnail Image
    Item
    Biomimetic camouflaged nanoparticles with selective cellular internalization and migration competences
    (Acta Biomaterialia, 2022) Jiménez Jiménez, Carla; Moreno Borrallo, Almudena; Dumontel, Bianca; Manzano, Miguel; Vallet Regí, María Dulce Nombre
    In the last few years, nanotechnology has revolutionized the potential treatment of different diseases. However, the use of nanoparticles for drug delivery might be limited by their immune clearance, poor biocompatibility and systemic immunotoxicity. Hypotheses for overcoming rejection from the body and increasing their biocompatibility include coating nanoparticles with cell membranes. Additionally, source cell-specific targeting has been reported when coating nanoparticles with tumor cells membranes. Here we show that coating mesoporous silica nanoparticles with membranes derived from preosteoblastic cells could be employed to develop potential treatments of certain bone diseases. These nanoparticles were selected because of their well-established drug delivery features. On the other hand MC3T3-E1 cells were selected because of their systemic migration capabilities towards bone defects. The coating process was here optimized ensuring their drug loading and delivery features. More importantly, our results demonstrated how camouflaged nanocarriers presented cellular selectivity and migration capability towards the preosteoblastic source cells, which might constitute the inspiration for future bone disease treatments.
  • Thumbnail Image
    Item
    Zinc oxide nanocrystals as nano-antibiotic and osteoinductive agents
    (RSC Advances, 2019) Garino, Nadia; Sanvitale, Pasquale; Dumontel, Bianca; Laurenti, Marco; Colilla Nieto, Montserrat; Izquierdo Barba, Isabel; Cauda, Valentina; Vallet Regí, María Dulce Nombre
    The use of nanomaterials in the field of bone tissue engineering implants is continuously dealing with the development of innovative solutions to common problems, as infection by colonization with common microbial agents, antibiotic bacterial resistance, and the formation of new bone tissue. Among them, ZnO nanostructures are promising candidates thanks to their intrinsic antimicrobial activity and high biocompatibility. In this paper we aim to analyse the behaviour of ZnO nanocrystals (ZnO NCs), prepared with a new synthetic approach and not embedded in any composite matrix, for bone implants applications in-vitro. In particular, we have developed a novel, fast and reproducible microwave-assisted synthesis, obtaining highly-crystalline, round-shaped ZnO NCs of 20 nm in diameter as an extremely-stable colloidal solution in ethanol. Part of them were also chemically functionalized by anchoring amino-propyl groups to the ZnO surface (ZnO-NH2 NCs). Thus, the role of both ZnO NCs concentration and surface chemistry are tested in terms of biocompatibility towards pre-osteoblasts cells, promotion of cell proliferation and differentiation, and also in terms of antimicrobial activity against Gram positive and negative bacteria, such as Escherichia coli and Staphylococcus aureus, respectively. The results propose the ZnO-NH2 NCs as the most promising candidate to solve infections disease in bone implants and promote bone tissue proliferation at the same time, even at high concentrations. Whereas further investigations are needed for example to clarify the mechanism inhibiting biofilm formation and to investigate their role in in-vivo assays, we demonstrated that a fine and reproducible control over the chemical and structural parameters in ZnO nanomaterials can open new horizons in the use of functionalized ZnO NCs as a highly biocompatible and osteoinductive nanoantibiotic agent for bone tissue engineering.